Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intravenous infusion and intralesional injection of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Skin Ulcer
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-12-02; most recent amendment 2025-04-15.
Status change: Suspended → Not Yet Recruiting 2025-04-15
Status change: Recruiting → Suspended 2022-10-13
Trial Details
NCT Number NCT05158127
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Skin Ulcer
Enrollment 20 participants
Start Date 2025-12
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-17